Evidence map›Paper›PMID 35132375›Full record

ArticleBioMed research international2022

Therapeutic Potential of Metabolites from

Samat Kozhakhmetov, Dmitriy Babenko, Saniya Kozhakhmetova, Altynay Tuyakova, Madiyar Nurgaziyev, Ayaulym Nurgozhina, Nurislam Muhanbetganov, Laura Chulenbayeva, Shynggys Sergazy, Alexander Gulyayev and 2 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BioMed research international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Therapeutic Potential of Metabolites fromBioMed research international · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Samat KozhakhmetovNational Laboratory Astana, Nazarbayev University, Nur-Sultan, Kazakhstan.ORCID https://orcid.org/0000-0001-9668-0327
Dmitriy BabenkoInnovation Center ArtScience, Nur-Sultan, Kazakhstan.ORCID https://orcid.org/0000-0003-2280-2146
Saniya KozhakhmetovaNational Center for Biotechnology, Nur-Sultan, Kazakhstan.ORCID https://orcid.org/0000-0002-8772-0507
Altynay TuyakovaNational Laboratory Astana, Nazarbayev University, Nur-Sultan, Kazakhstan.ORCID https://orcid.org/0000-0002-7649-2430
Madiyar NurgaziyevNational Laboratory Astana, Nazarbayev University, Nur-Sultan, Kazakhstan.ORCID https://orcid.org/0000-0003-2397-4978
Ayaulym NurgozhinaNational Laboratory Astana, Nazarbayev University, Nur-Sultan, Kazakhstan.ORCID https://orcid.org/0000-0001-7042-4763
Nurislam MuhanbetganovNational Laboratory Astana, Nazarbayev University, Nur-Sultan, Kazakhstan.ORCID https://orcid.org/0000-0002-6708-7871
Laura ChulenbayevaNational Laboratory Astana, Nazarbayev University, Nur-Sultan, Kazakhstan.ORCID https://orcid.org/0000-0002-8691-9485
Shynggys SergazyNational Laboratory Astana, Nazarbayev University, Nur-Sultan, Kazakhstan.
Alexander GulyayevNational Laboratory Astana, Nazarbayev University, Nur-Sultan, Kazakhstan.ORCID https://orcid.org/0000-0001-5098-4675
Mohamad AljofanDepartment of Biomedical Sciences, School of Medicine, Nazarbayev University, Nur-Sultan, Kazakhstan.
Almagul KushugulovaNational Laboratory Astana, Nazarbayev University, Nur-Sultan, Kazakhstan.ORCID https://orcid.org/0000-0001-9479-0899
Nazarbayev University · KZEurasian Humanities Institute · KZNational Center for Biotechnology · KZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ulcerative colitis is an inflammatory bowel disease that forms ulcerations in the mucous membrane of the colon and rectum, in which gut microbiota plays a pivotal role in its pathogenesis. Agents modulating microbial dysbiosis caused by colitis can help in the remission of this disease. The current study describes the potential therapeutic effects of active metabolites from

Indexed as

AnimalsColitis, UlcerativeCytokinesDextran SulfateDisease Models, AnimalDysbiosisGastrointestinal MicrobiomeHorsesLacticaseibacillus rhamnosusMesalamineMilkRatsRats, WistarCytokinesDextran SulfateMesalamine

Identifiers

PMID35132375
PMCPMC8817857
OpenAlexW4213074128

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.